Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Genetic risk factors for portopulmonary hypertension in patients with advanced liver disease.

American journal of respiratory and critical care medicine - 1 May 2009

Roberts Kari E, Fallon Michael B, Krowka Michael J, Brown Robert S, Trotter James F, Peter Inga, Tighiouart Hocine, Knowles James A, Rabinowitz Daniel, Benza Raymond L, Badesch David B, Taichman Darren B, Horn Evelyn M, Zacks Steven, Kaplowitz Neil, Kawut Steven M

Abstract excerpt

RATIONALE: Portopulmonary hypertension (PPHTN) occurs in 6% of liver transplant candidates. The pathogenesis of this complication of portal hypertension is poorly understood. OBJECTIVES: To identify genetic risk factors for PPHTN in patients with advanced liver disease. METHODS: We performed a mu...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Angiopoietin-1
Share to Aromatase

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Calcium-Binding Proteins

Share to Estradiol

Share to Estrogen Receptor alpha

Share to Hypertension, Portal

Share to Liver Diseases

Share to Receptors, Retinoic Acid

Source

Open in PubMed Open full text

Identifiers

PMID: 19218192
DOI: 10.1164/rccm.200809-1472OC
PMCID: PMC2675568

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026. Prepared record publication-19218192-2026-09-02.2. Manifest publication-graph-cohort-2026-09-02.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Genetic risk factors for portopulmonary hypertension in patients with advanced liver disease.PMID 19218192Read ↗

Genetic risk factors for hepatopulmonary syndrome in patients with advanced liver disease.Semantic proximity Read ↗

Estrogen Signaling and Portopulmonary Hypertension: The Pulmonary Vascular Complications of Liver Disease Study (PVCLD2).Semantic proximity Read ↗

The genetics of portal hypertension: Recent developments and the road aheadSemantic proximity Read ↗

Co-expression gene network analysis reveals novel regulatory pathways involved in porto-sinusoidal vascular diseaseSemantic proximity Read ↗

Genome-wide association analyses identified novel susceptibility loci for pulmonary embolism among Han Chinese population.Semantic proximity Read ↗

Genetics of liver disease: From pathophysiology to clinical practice.Semantic proximity Read ↗

Genetics and genomics of primary biliary cirrhosis.Semantic proximity Read ↗

Human liver single nuclear RNA sequencing implicates BMPR2, GDF15, arginine, and estrogen in portopulmonary hypertensionSemantic proximity Read ↗

the Utility of Genome-Wide Association Studies in HepatologySemantic proximity Read ↗

Genetic predisposition to porto-sinusoidal vascular disorderSemantic proximity Read ↗

Mutational screening in genes related with porto-pulmonary hypertension: An analysis of 6 cases.Semantic proximity Read ↗

Clinical aspects of portopulmonary hypertension.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.